Drugs / Yuxuebi
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04934059 | Jul 2021 → Jan 2022 | ankylosing spondylitis | China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yuxuebi | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04934059 ↗ |